|
This bill
requires carriers offering health plans in this State to provide coverage for
blood testing for perfluoroalkyl and polyfluoroalkyl substances. The
requirements of the bill apply to health plans issued or renewed on or after
January 1, 2027. The bill includes General Fund appropriations to the
Department of Administrative and Financial Services of $90,000 for the
estimated cost to reimburse the insurance carriers, for 6 months of the
State's defrayal cost of this new mandate. The mandate will go into effect on
all health insurance plans on the marketplace beginning January 1, 2027 and
is estimated to cost $180,000 annually, thereafter.
The State Employee Health Plan's first impacted plan year will be fiscal
year 2027-28 and is estimated to cost $57,313 annually thereafter. The costs
are split across the General Fund ($26,364), Highway Fund ($9,170) and all
other funds ($21,779). |